Forvis Wealth Advisors, LLC Eli Lilly & CO Transaction History

Forvis Wealth Advisors, LLC

$4.26 Billion
Q3 2024

A detailed history of Forvis Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Forvis Wealth Advisors, LLC holds 51,581 shares of LLY stock, worth $39.9 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

51,581

Previous 44,111 16.93%

Holding current value

$39.9 Million

Previous $39.9 Million 14.42%

% of portfolio

1.07%

Previous 1.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $5.77 Million - $7.17 Million	7,470 Added 16.93%	51,581 $45.7 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $12.8 Million - $16.1 Million	-17,708 Reduced 28.64%	44,111 $39.9 Million
Q1 2024 Apr 19, 2024	BUY	$592.2 - $792.28 $10.2 Million - $13.6 Million	17,222 Added 38.62%	61,819 $48.1 Million
Q4 2023 Jan 11, 2024	BUY	$525.19 - $619.13 $121,318 - $143,019	231 Added 0.52%	44,597 $26 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $2.87 Million - $3.96 Million	-6,604 Reduced 12.96%	44,366 $23.8 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $50,506 - $67,533	144 Added 0.28%	50,970 $23.9 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $2.13 Million - $2.5 Million	-6,844 Reduced 11.87%	50,826 $17.5 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $2.33 Million - $2.72 Million	-7,250 Reduced 11.17%	57,670 $21.1 Million
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $387,795 - $441,933	1,308 Added 2.06%	64,920 $21 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $5.17 Million - $6.07 Million	18,558 Added 41.19%	63,612 $20.6 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $76,978 - $95,664	-328 Reduced 0.72%	45,054 $12.9 Million
Q4 2021 Jan 14, 2022	SELL	$224.85 - $279.04 $781,803 - $970,222	-3,477 Reduced 7.12%	45,382 $12.5 Million
Q3 2021 Oct 14, 2021	BUY	$221.6 - $272.71 $1.78 Million - $2.19 Million	8,027 Added 19.66%	48,859 $11.3 Million
Q2 2021 Jul 14, 2021	SELL	$180.55 - $233.54 $362,183 - $468,481	-2,006 Reduced 4.68%	40,832 $9.37 Million
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $2.54 Million - $3.29 Million	-15,458 Reduced 26.52%	42,838 $8 Million
Q4 2020 Jan 22, 2021	BUY	$130.46 - $172.63 $215,128 - $284,666	1,649 Added 2.91%	58,296 $9.84 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $3.17 Million - $3.67 Million	21,697 Added 62.08%	56,647 $8.39 Million
Q2 2020 Jul 15, 2020	BUY	$136.42 - $164.18 $18,553 - $22,328	136 Added 0.39%	34,950 $5.74 Million
Q1 2020 Apr 10, 2020	BUY	$119.05 - $147.35 $98,930 - $122,447	831 Added 2.45%	34,814 $4.83 Million
Q4 2019 Jan 13, 2020	BUY	$106.92 - $132.43 $56,774 - $70,320	531 Added 1.59%	33,983 $4.47 Million
Q3 2019 Oct 29, 2019	BUY	$106.79 - $116.16 $4,591 - $4,994	43 Added 0.13%	33,452 $3.74 Million
Q2 2019 Jul 10, 2019	SELL	$110.79 - $129.32 $2.89 Million - $3.38 Million	-26,121 Reduced 43.88%	33,409 $3.7 Million
Q1 2019 Apr 10, 2019	BUY	$111.31 - $131.02 $6.63 Million - $7.8 Million	59,530 New	59,530 $7.73 Million
Q4 2018 Jan 15, 2019	SELL	$105.9 - $118.64 $6.37 Million - $7.14 Million	-60,147 Closed	0 $0
Q3 2018 Oct 09, 2018	SELL	$85.86 - $107.31 $11,247 - $14,057	-131 Reduced 0.22%	60,147 $6.45 Million
Q2 2018 Jul 13, 2018	SELL	$75.7 - $86.88 $60,105 - $68,982	-794 Reduced 1.3%	60,278 $5.14 Million
Q1 2018 May 25, 2018	SELL	$74.21 - $87.6 $2,374 - $2,803	-32 Reduced 0.05%	61,072 $4.73 Million
Q1 2018 Apr 20, 2018	BUY	$74.21 - $87.6 $4.53 Million - $5.35 Million	61,104 New	61,104 $4.87 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forvis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forvis Wealth Advisors, LLC with notifications on news.

Account

Forvis Wealth Advisors, LLC Eli Lilly & CO Transaction History